News

Blocklisting Interim Review
19 June 2013

TyraTech, Inc. (AIM: TYR), a natural life sciences company, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:

Name of company: TyraTech, Inc.
Name of scheme:     2007 Equity Compensation Plan of the Company
Period of return: From: 17 December 2012 To: 18 June 2013
Number and class of securities not issued
under the scheme
5,164,996 common shares
Number of securities issued under the
scheme during the period
Nil
Balance under the scheme of securities not
yet issued at the end of the period
5,164,996 common shares
Number and class of securities originally
admitted and the date of admission
5,183,746 common shares on 2 March 2011
Name of contact: Daniel Williams
Telephone number of contact: +1 919 415 4285

 

For further information please contact:

TyraTech Inc.
Alan Reade, Executive Chairman
Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4310
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 7496 3000
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford /Guy McDougall (Public Relations)
Paul Cornelius (Investor Relations)

Tel: +44 20 7933 8792
Tel: +44 20 7933 8794

 

<< Back to News releases

Disclaimer for U.S. Site Visitors

This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.